Search

everythinglearnresearchcommunity

for

Search:↓

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Dupilumab can help hair regrowth but may also trigger alopecia areata.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

Intralesional steroid injections can effectively treat calcinosis and ulcers in scleroderma.

Entospletinib effectively prevents eye and skin GVHD in mice.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

TNF-alpha inhibitors can cause various immune-related skin issues.